Literature DB >> 1028381

[In vitro culture of a rotavirus associated with neonatal calf diarrhea].

R L'Haridon, R Scherrer.   

Abstract

About fifty diarrheic fecal samples in which the calf rotavirus was present in variable quantities were passed in tissue cultures and the ability of the virus to replicate was analysed under different experimental conditions by means of an indirect immunoflourescent test. Several cell species were shown to be susceptible to the virus but the best results were obtained in primary or secondary cultures of embryonic calf kidney cells in presence of maintainance medium containing 2 to 4 p. 100 foetal calf serum or chick serum. The specific infectivity of this type of virus is low in tissue culture. Under the best experimental conditions about 70 p. 100 of the samples that were positive for the virus by electron microscopy, induced the appearance of specifically fluorescent cells. Cytopathic effects due to infection are extremely discreet and most often there is no evidence of transfer of infection from cell to cell. Different attempts to adapt the infective agent to grow in tissue culture finally succeeded in the selection of a virus that was able to induce fluorescnet plaques at the fifth pass.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1028381

Source DB:  PubMed          Journal:  Ann Rech Vet        ISSN: 0003-4193


  14 in total

1.  Rafts promote assembly and atypical targeting of a nonenveloped virus, rotavirus, in Caco-2 cells.

Authors:  Catherine Sapin; Odile Colard; Olivier Delmas; Cedric Tessier; Michelyne Breton; Vincent Enouf; Serge Chwetzoff; Jocelyne Ouanich; Jean Cohen; Claude Wolf; Germain Trugnan
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Hsp70 negatively controls rotavirus protein bioavailability in caco-2 cells infected by the rotavirus RF strain.

Authors:  Alexis H Broquet; Christelle Lenoir; Agnès Gardet; Catherine Sapin; Serge Chwetzoff; Anne-Marie Jouniaux; Susana Lopez; Germain Trugnan; Maria Bachelet; Ginette Thomas
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

3.  Analysis of the structural polypeptides of a porcine group C rotavirus.

Authors:  M Bremont; J Cohen; M A McCrae
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

4.  Expression of two bovine rotavirus non-structural proteins (NSP2, NSP3) in the baculovirus system and production of monoclonal antibodies directed against the expressed proteins.

Authors:  C Aponte; N M Mattion; M K Estes; A Charpilienne; J Cohen
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  Recovery and characterization of a replicase complex in rotavirus-infected cells by using a monoclonal antibody against NSP2.

Authors:  C Aponte; D Poncet; J Cohen
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

6.  Simian rotavirus (SA 11) in serodiagnosis of human rotavirus infections.

Authors:  L Brade; W A Schmidt
Journal:  Med Microbiol Immunol       Date:  1979-03-13       Impact factor: 3.402

7.  Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice.

Authors:  Davide Agnello; Christine A Hervé; Amandine Lavaux; Magali Darniot; Patrice Guillon; Annie Charpilienne; Pierre Pothier
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Rotavirus-like particles: a novel nanocarrier for the gut.

Authors:  Naima G Cortes-Perez; Catherine Sapin; Loïc Jaffrelo; Sabine Daou; Jean Pierre Grill; Philippe Langella; Philippe Seksik; Laurent Beaugerie; Serge Chwetzoff; Germain Trugnan
Journal:  J Biomed Biotechnol       Date:  2010-04-13

9.  Expression of rotavirus VP2 produces empty corelike particles.

Authors:  M Labbé; A Charpilienne; S E Crawford; M K Estes; J Cohen
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

10.  Weak susceptibility of rotavirus to bovine interferon in calf kidney cells.

Authors:  C La Bonnardiere; C de Vaureix; R L'Haridon; R Scherrer
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.